Blog

Clinical development of immunotherapy for prostate cancer. – UroToday

Clinical development of immunotherapy for prostate cancer.
UroToday
Recently, it has been recognized that immunotherapy is an effective treatment for prostate cancer patients. Several strategies, such as cancer vaccines and immune checkpoint inhibitors, have been investigated in clinical studies for prostate cancer

and more »

2017-06-29 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.